Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1

Status

Completed 24Terminated 9Unknown 7Recruiting 5Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 3NET 1Genitourinary 1Endocrine 1

Conditions

Breast Neoplasms 12Neuroendocrine Tumors 5Neoplasm Metastasis 5Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 3Adenoma, Islet Cell 3Recurrence 2Meningioma 2Glioblastoma 2Diffuse Intrinsic Pontine Glioma 2Carcinoma, Hepatocellular 2Carcinoid Tumor 2von Hippel-Lindau Disease 1Unilateral Breast Neoplasms 1Tuberous Sclerosis 1Thymus Neoplasms 1Sarcoma 1Neoplasms 1Metastatic Digestive System Neuroendocrine Tumor G1 1Lymphangioleiomyomatosis 1Locally Advanced Thyroid Gland Carcinoma 1Kidney Neoplasms 1HR+/HER2- Advanced Breast Cancer 1Glioma 1Gastroenteropancreatic Neuroendocrine Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Gallbladder Neoplasms 1Disease Progression 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 47Specimen Handling 29Magnetic Resonance Spectroscopy 25Biopsy 25Radiosurgery 17Gemcitabine 17Nivolumab 15Paclitaxel 14Cyclophosphamide 13Cisplatin 13Carboplatin 13Bevacizumab 12Drug Therapy 11Taxes 10Radiotherapy 10Oxaliplatin 10Leucovorin 10Irinotecan 10Fluorouracil 10Capecitabine 10trastuzumab deruxtecan 8fludarabine 8Pemetrexed 8Doxorubicin 8Cetuximab 8cemiplimab 7abemaciclib 7Trastuzumab 7Fulvestrant 7Docetaxel 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Neoplasm Metastasis × Everolimus × Clear all
NCT04802759 2026-05-11

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Hoffmann-La Roche

Phase 1/2 Recruiting
316 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06943755 2026-04-17

STELLAR-311

Exelixis

Phase 2/3 Recruiting
440 enrolled
EndocrineNET

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT05933395 2026-01-20

GERTRUDE

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
135 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02029001 2025-08-07

MOST plus

Centre Leon Berard

Phase 2 Recruiting
900 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05188118 2024-11-06

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

Icahn School of Medicine at Mount Sinai

Phase EARLY_PHASE1 Recruiting
20 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡